Table 1 Baseline characteristics in metastatic male breast cancer patients treated with first-line chemotherapy following endocrine therapy (N = 50)

Age

 Median

66

-

 Range

24-78

-

ECOG PS

 Median

1

-

 Range

0-2

-

Hormone receptor status

 Positive

48

96

 Unknown

2

4

HER2 status

 Negative

19

38

 Unknown

31

62

Adjuvant CT

 Yes

5

10

 No

45

90

Lines of HT for advanced disease

 Median

1

-

 Range

1-3

-

Dominant disease site

 Visceral

38

76

 Bone

10

20

 Soft-tissue

2

4

Number of disease sites

 1

10

20

 2

25

50

 ≥3

15

30

Chemotherapy regimens

 FAC

21

42

 FEC

11

22

 TEC

3

6

 CMF (intravenous)

10

20

 CMF (oral)

5

10